Annie Hoey (Labour) | Oireachtas source

There are a couple of eHealth Ireland initiatives with European funding, including the ePharmacy programme. What other technology or plans are in the pipeline related to Sláintecare? Has there been any change in plans or strategy as a result of learning from the Covid-19 pandemic? The conversation has sped along when it comes to telemedicine. Have the witnesses any further thoughts on that?

I will follow up Deputy Shortall's question around user fees as I know the witness was tight on time. She might want to elaborate on that. There has been quite a lively outcry online relating to consultant Sláintecare contracts, so what is the plan to deal with that? I have certainly been contacted by a number of people who have expressed concerns around them. What will happen in that area?

A question has arisen a couple of times when speaking about Sláintecare, which is supposed to be a public health service model for all, but there will still be private health insurance. How do the witnesses envisage these living together? I am struggling somewhat to see how we will have a Sláintecare model working to the effectiveness we want it to if there is a private health insurance sector also pushing and shoving in that space.